HEATHER JANSEN: Open Payments
NPI 1285388504 · NISKAYUNA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,226 in 54 payments from 12 companies in 2025. Trend: 2023 $1,483 · 2024 $755 · 2025 $1,226
Food & beverage: $1,226
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $236 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $221 |
| Teva Pharmaceuticals USA, Inc. | 8 | $138 |
| Janssen Pharmaceuticals, Inc | 5 | $133 |
| E.R. Squibb & Sons, L.L.C. | 1 | $115 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $97 |
| Neurocrine BioSciences, Inc. | 3 | $77 |
| Vanda Pharmaceuticals Inc. | 4 | $75 |
| Axsome Therapeutics, Inc. | 2 | $44 |
| Alkermes, Inc. | 2 | $41 |
Products named: VRAYLAR, CAPLYTA, COBENFY, TRINTELLIX, SPRAVATO, AUSTEDO XR, INGREZZA, FANAPT.
Industry payments across NY — which companies pay providers there.
